Modification of the adenoviral transfer vector enhances expression of the Hantavirus fusion protein GnS0.7 and induces a strong immune response in C57BL/6 mice.

Hantavirus glycoproteins (Gn and Gc) are significant components of vaccines for haemorrhagic fever with renal syndrome (HFRS); however, they are not effective due to weak immunogenicity and low levels of production in expression systems. To circumvent this problem, a 0.7-kb fragment of the S segment was fused to Gn, and a hybrid CAG promoter/enhancer in conjunction with (or without) the WPRE (Woodchuck hepatitis virus post-transcriptional regulatory element) was used to improve the expression of fusion protein GnS0.7 in the adenoviral expression system. The expression level of the fusion protein as well as the response of mice immunized with recombinant adenoviruses containing GnS0.7 was investigated. In addition, a series of immunological assays were conducted to determine the immunogenicity of the recombinant adenoviruses. The results showed that the recombinant adenovirus with the CAG promoter/enhancer (rAd-GnS0.7-pCAG) expressed approximately 2.1-fold more GnS0.7 than the unmodified recombinant adenovirus containing GnS0.7 (rAd-GnS0.7-pShuttle). This enhanced expression level was also higher than for other modified recombinant adenoviruses studied. Animal experiments showed that rAd-GnS0.7-pCAG induced a stronger Hantaan virus (HTNV)-specific humoral and cellular immune response in mice, with the cellular immune response to the GnS0.7 being stronger than the HFRS vaccine control. These results demonstrate that the CAG promoter/enhancer improved significantly the expression of the chimeric gene GnS0.7 in the adenovirus expression system. These findings may have significant implications for the development of genetically engineered vaccines for HFRS.
AuthorsPu-Yuan Li, Lan Yu, Xing-An Wu, Wen-Tao Bai, Kai Li, Hai-Tao Wang, Gang Hu, Liang Zhang, Fang-Lin Zhang, Zhi-Kai Xu
JournalJournal of virological methods (J Virol Methods) Vol. 179 Issue 1 Pg. 90-6 (Jan 2012) ISSN: 1879-0984 [Electronic] Netherlands
PMID22015676 (Publication Type: Journal Article, Research Support, Non-U.S. Gov't)
CopyrightCopyright © 2011 Elsevier B.V. All rights reserved.
Chemical References
  • Antibodies, Viral
  • Antigens, Viral
  • Drug Carriers
  • Recombinant Fusion Proteins
  • Viral Vaccines
  • Adenoviridae (genetics)
  • Animals
  • Antibodies, Viral (blood)
  • Antigens, Viral (genetics, immunology)
  • Drug Carriers
  • Female
  • Genetic Vectors
  • Hantavirus (genetics, immunology)
  • Leukocytes, Mononuclear (immunology)
  • Mice
  • Mice, Inbred C57BL
  • Promoter Regions, Genetic
  • Recombinant Fusion Proteins (genetics, immunology)
  • Viral Vaccines (administration & dosage, genetics, immunology)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research network!

Choose Username:
Verify Password: